Related Experiment Videos
A sliding intravenous dose schedule for clonidine in hypertensive patients
Insights
Intravenous clonidine effectively lowered blood pressure and heart rate in hypertensive patients. Individual responses to clonidine varied, with no correlation to baseline blood pressure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension is a significant risk factor for cardiovascular disease.
- Effective antihypertensive agents are crucial for managing blood pressure.
- Clonidine is an alpha-2 adrenergic agonist with known hypotensive properties.
Purpose of the Study:
- To evaluate the dose-response relationship of intravenous clonidine in hypertensive patients.
- To assess the impact of clonidine on mean arterial pressure and heart rate.
Main Methods:
- Eight hypertensive patients received cumulative intravenous doses of clonidine.
- Dosing continued until a maximal dose of 100 mug or normalization of blood pressure was achieved.
- Mean arterial pressure and heart rate were monitored throughout the study.
Main Results:
- A significant reduction in mean arterial pressure (35.6 mm Hg) and heart rate (11.8 bpm) was observed (p < 0.001).
- A linear relationship existed between the log dose of clonidine and blood pressure reduction, with a 6.5-fold difference in potency.
- No correlation was found between baseline blood pressure and the dose-response curves or the extent of blood pressure reduction.
Conclusions:
- Intravenous clonidine demonstrates significant hypotensive and heart rate-lowering effects in hypertensive patients.
- Patient response to clonidine varies, and the rate of decline in its hypotensive effect is unpredictable and not related to baseline blood pressure.
Abstract:
Cumulative doses of clonidine were administered intravenously to 8 hypertensive patients to a maximal dose of 100 mug or a blood pressure fall to normal. There was a reduction in mean arterial pressure of 35.6 mm Hg (p less than 0.001), accompanied by a decrease in heart rate of 11.8 bpm (p less than 0.001). There was also a significant linear relationship between the reduction in blood pressure and the intravenous log dose of clonidine with 6.5-fold difference in delta MAP/dose potency. There was no correlation between the baseline blood pressure and the slopes of dose-blood pressure response curves or the reduction in mean arterial pressure; the rate of the decline of the hypotensive effect of clonidine varied widely between patients and was not related to baseline blood pressure.